Low dose oxybutynin for the unstable bladder.
作者信息
Malone-Lee J, Lubel D, Szonyi G
出版信息
BMJ. 1992 Apr 18;304(6833):1053. doi: 10.1136/bmj.304.6833.1053.
Abstract
摘要
相似文献
1
Low dose oxybutynin for the unstable bladder.低剂量奥昔布宁治疗膀胱不稳定症。
BMJ. 1992 Apr 18;304(6833):1053. doi: 10.1136/bmj.304.6833.1053.
2
Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.奥昔布宁膀胱内灌注治疗特发性逼尿肌不稳定女性患者：一项随机试验。
Br J Obstet Gynaecol. 1995 Nov;102(11):929-30. doi: 10.1111/j.1471-0528.1995.tb10885.x.
3
[Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].[盐酸奥昔布宁局部给药治疗女性急迫性尿失禁。一项前瞻性随机双盲研究的结果]
Geburtshilfe Frauenheilkd. 1995 May;55(5):240-3. doi: 10.1055/s-2007-1023310.
4
Case 7: the addled nonagenarian.
J Clin Psychopharmacol. 1995 Oct;15(5):378.
5
[Topical treatment with oxybutynin chloride in neurogenic incontinence].[用氯化奥昔布宁进行神经源性尿失禁的局部治疗]
Cir Pediatr. 1993 Jan;6(1):29-31.
6
Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.膀胱内奥昔布宁剂量递增治疗神经源性膀胱患者
Spinal Cord. 2000 Apr;38(4):250-4. doi: 10.1038/sj.sc.3100995.
7
8
Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.盐酸奥昔布宁膀胱内灌注治疗神经源性膀胱患者。
Paraplegia. 1994 Jan;32(1):25-9. doi: 10.1038/sc.1994.5.
9
[Topical use of oxybutynin hydrochloride in women with urge incontinence].盐酸奥昔布宁在急迫性尿失禁女性中的局部应用
Gynakol Geburtshilfliche Rundsch. 1994;34(1):23-4. doi: 10.1159/000272324.
10
Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
Br J Urol. 1993 Nov;72(5 Pt 1):566-70. doi: 10.1111/j.1464-410x.1993.tb16210.x.
引用本文的文献
1
Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience.米拉贝隆单药及联合用药治疗膀胱过度活动症：真实世界证据与经验
Ther Adv Urol. 2018 Sep 26;10(12):411-419. doi: 10.1177/1756287218801282. eCollection 2018 Dec.
2
CUA guideline on adult overactive bladder.加拿大泌尿外科学会成人膀胱过度活动症指南
Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9.
3
Selecting a medical therapy for overactive bladder.选择治疗膀胱过度活动症的药物疗法。
Rev Urol. 2002;4 Suppl 4(Suppl 4):S28-37.
4
Clinical pharmacology of old age syndromes.老年综合征的临床药理学
Br J Clin Pharmacol. 2003 Sep;56(3):261-72. doi: 10.1046/j.0306-5251.2003.01877.x.
5
Pharmacologic treatment for detrusor overactivity.
Curr Urol Rep. 2002 Oct;3(5):365-72. doi: 10.1007/s11934-002-0078-4.
6
Economics of lower urinary tract symptoms (LUTS) in older people.老年人下尿路症状（LUTS）的经济学分析
Drugs Aging. 2001;18(3):213-23. doi: 10.2165/00002512-200118030-00006.
7
Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
Drugs Aging. 1995 Mar;6(3):243-62. doi: 10.2165/00002512-199506030-00007.
本文引用的文献
1
The pharmacokinetics of oxybutynin in man.奥昔布宁在人体中的药代动力学。
Eur J Clin Pharmacol. 1988;35(5):515-20. doi: 10.1007/BF00558247.
Zotero 插件